Long-Term Persistence of Anti-SARS-CoV-2 Antibodies in a Pediatric Population

Ana Méndez-Echevarría1, Talía Sainz1, Iker Falces-Romero2

  • 1Pediatrics and Infectious Disease Unit, La Paz University Hospital, Translational Research Network of Pediatric Infectious Diseases (RITIP), 28049 Madrid, Spain.

Insights

Most children infected with SARS-CoV-2 maintain positive IgG antibodies six months post-infection. Antibody loss was more common in asymptomatic or mildly symptomatic children with initially low antibody titers.

Area of Science:

  • Pediatric Infectious Diseases
  • Immunology
  • Virology

Background:

  • Antibody dynamics following SARS-CoV-2 infection in children remain poorly understood.
  • Limited data exists on long-term antibody responses in pediatric populations.

Purpose of the Study:

  • To investigate the persistence of SARS-CoV-2 specific IgG antibodies in children up to six months post-infection.
  • To identify factors associated with antibody loss in pediatric COVID-19 cases.

Main Methods:

  • A prospective cohort study involving 58 children infected with SARS-CoV-2 between March and May 2020.
  • Children were categorized into hospitalized COVID-19, mild outpatient COVID-19, and asymptomatic seropositive contacts.
  • Serological testing for IgG antibodies was performed at baseline and six months post-infection.

Main Results:

  • 86% of children maintained positive IgG antibodies six months after infection.
  • Higher initial IgG titers and diagnoses of lower respiratory tract infection or multisystemic inflammatory syndrome were associated with sustained antibody response.
  • Children of healthcare workers in the seroprevalence study lost antibodies more frequently.

Conclusions:

  • The majority of children infected with SARS-CoV-2 exhibit sustained IgG antibody responses six months post-infection.
  • Antibody loss is more likely in children with asymptomatic or mild infections and lower initial antibody titers.
Abstract

Related Concept Videos

Immunological Memory01:23

Immunological Memory

Immunological memory, a pivotal pillar of the adaptive immune system, is responsible for the body's ability to remember and respond more swiftly and effectively to previously encountered pathogens. This remarkable feature is what makes vaccines so effective in preventing diseases.
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature...
12.5K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
55
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
68
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
539
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
49
Active versus Passive Immunity01:31

Active versus Passive Immunity

Immunity, along with the ability to limit pathogen growth to prevent significant body tissue damage, can be gained either by (1) actively developing an immune response within the individual after exposure to a pathogen or after getting vaccinated or (2) passively transferring immune components from an immune individual to one who is nonimmune. Both these forms of immunity can be found naturally and in medical practices.
Active Immunity
Active immunity refers to the resistance one develops...
8.0K